Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,765 products)
- Apoptosis(6,237 products)
- Cell Cycle/Checkpoint(4,778 products)
- Chromatin/Epigenetics(2,426 products)
- Cytoskeletal Signaling(1,515 products)
- DNA Damage/DNA Repair(2,957 products)
- Endocrinology/Hormones(3,692 products)
- Enzyme(3,665 products)
- GPCR/G-Protein(8,968 products)
- Immunology and Inflammation(3,857 products)
- Influenza Virus(301 products)
- JAK/STAT signaling(413 products)
- MAPK Signaling(1,249 products)
- Membrane Transporter/Ion Channel(3,024 products)
- Metabolism(10,184 products)
- Microbiology/Virology(7,551 products)
- Neuroscience(10,359 products)
- Other Inhibitors(36,088 products)
- Oxidation-Reduction(43 products)
- PI3K/Akt/mTOR Signaling(1,444 products)
- Proteases/Proteasome(1,718 products)
- Stem Cell and Derivatives(825 products)
- Tyrosine Kinase/Adaptors(2,035 products)
- Ubiquitination(1,710 products)
Show 16 more subcategories
Found 66669 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
SR 142948
CAS:SR 142948 is a neurotensin (NT) receptor antagonist.Formula:C39H51N5O6Purity:98%Color and Shape:SolidMolecular weight:685.85Mutant IDH1-IN-2
CAS:Mutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of 16.6 nM in Fluorescence biochemical assay, IC50 of ＜22 nM in LS-Formula:C24H31F2N5O2Purity:99.88%Color and Shape:SolidMolecular weight:459.53Lumateperone
CAS:<p>Lumateperone (ITI 722) is a 5HT2A receptor antagonist and a dopamine receptor phosphoprotein modulator (DPPM).</p>Formula:C24H28FN3OPurity:99.68% - 99.91%Color and Shape:SolidMolecular weight:393.5Y06137
CAS:<p>Y06137, selective BET inhibitor, Kd 81 nM for BRD4(1), researched for castration-resistant prostate cancer treatment.</p>Formula:C27H32N4O2Purity:99.85%Color and Shape:SolidMolecular weight:444.57AMG2850
CAS:AMG2850 is a potent, orally bioavailable, and selective antagonist of transient receptor potential melastatin 8 (TRPM8).Formula:C19H17F6N3OPurity:99.84%Color and Shape:SolidMolecular weight:417.35CeMMEC1
CAS:CeMMEC1 is an inhibitor of BRD4, and also has a great affinity for TAF1(IC50=0.9 μM).Formula:C19H16N2O4Purity:98.9% - 99.92%Color and Shape:SolidMolecular weight:336.34VBY-825
CAS:VBY-825 is a reversible inhibitor of cathepsin with high potency against cathepsins B, L, S and V.Formula:C23H29F4N3O5SPurity:99.91%Color and Shape:SolidMolecular weight:535.55PKC-IN-1
CAS:PKC-IN-1 is an ATP-competitive and reversible conventional PKC enzymes inhibitor (PKCα, PKCβI, PKCβII, PKCθ, PKCγ, PKC mu and PKCε with IC50s of 2.3, 8.1, 7.6,Formula:C25H37FN8O2Purity:98% - 98.79%Color and Shape:SolidMolecular weight:500.61Src Inhibitor 3
CAS:Src Inhibitor 3 blocks c-Src kinase (IC50 <3 nM CSK HTRF, <4 nM Caliper), boosting T cell growth from receptor signals.Formula:C34H32ClFN8O4Purity:98.35%Color and Shape:SolidMolecular weight:671.12SB-616234-A
CAS:SB-616234-A is a selective and orally bioavailable antagonist of 5-HT1B receptor, with anxiolytic and antidepressant activity.Formula:C32H36ClN5O3Purity:99.72%Color and Shape:SolidMolecular weight:574.11AZ-23
CAS:AZ-23 is an inhibitor of ATP-competitive and Trk kinase A/B/C.Formula:C17H19ClFN7OPurity:99.4%Color and Shape:SolidMolecular weight:391.83PXS-5120A
CAS:PXS-5120A is an irreversible fluoroallylamine Lysyl Oxidase-like 2/3 (LOXL2/3) inhibitor with anti-fibrotic activity.Formula:C22H25ClFN3O4SPurity:97.02%Color and Shape:SolidMolecular weight:481.97PKI-402
CAS:PKI-402 is a potent PI3K and mTOR inhibitor. PKI-402 inhibits PI3Kα, mTOR, PI3Kβ, PI3Kδ and PI3Kγ with IC50s of 2, 3, 7, 14 and 16 nM, respectively.Formula:C29H34N10O3Purity:99.94%Color and Shape:SolidMolecular weight:570.65PF-04979064
CAS:<p>PF-04979064 is a potent and selective PI3K and mTOR dual kinase inhibitor(Ki of 0.13 nM and 1.42 nM,respectively).</p>Formula:C24H26N6O3Purity:98.20% - ≥98%Color and Shape:SolidMolecular weight:446.5HM43239
CAS:HM43239: oral FLT3 inhibitor; IC50: FLT3 WT 1.1nM, ITD 1.8nM, D835Y 1.0nM; blocks p-STAT5/p-ERK; affects SYK, JAK1/2, TAK1; halts leukemia cell growth.Formula:C29H33ClN6Purity:99.7%Color and Shape:SolidMolecular weight:501.07GSK-3 inhibitor 1
CAS:GSK-3 inhibitor 1 is a GSK-3 inhibitor.Formula:C22H17ClFN5O2Purity:98.42%Color and Shape:SolidMolecular weight:437.85Lomibuvir
CAS:Lomibuvir (VCH-222, VX-222) is an allosteric inhibitor of HCV NS5B with Kd 17 nM, blocks RNA elongation, EC50 5.2 nM for 1b/Con1.Formula:C25H35NO4SPurity:99.83%Color and Shape:SolidMolecular weight:445.61GSK-F1
CAS:GSK-F1 (PI4KA inhibitor-F1) is a novel potent PI4KA inhibitor.Formula:C27H18F5N5O4SPurity:97.03%Color and Shape:SolidMolecular weight:603.52EGFR-IN-8
CAS:<p>EGFR-IN-8, a dual inhibitor targeting both EGFR and c-Met, shows potential as a promising candidate for further development in treating EGFR TKI-resistant NSCLC</p>Formula:C32H23ClF3N7O4Purity:99.51%Color and Shape:SolidMolecular weight:662.02GDC-0349
CAS:<p>GDC-0349 (RG-7603) is a potent and selective ATP-competitive inhibitor of mTOR, 790-fold inhibitory effect against PI3Kα and other 266 kinases. Phase 1.</p>Formula:C24H32N6O3Purity:96.00% - 98.17%Color and Shape:SolidMolecular weight:452.55
